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Objective: to evaluate early and mid-term term results of carotid endarterectomy (CEA) in patient with and without
contralateral carotid occlusion.
Methods: between 1996 and 1999, 1324 CEAs were performed. In 82 patients contralateral carotid artery occlusion was
present (group I); 1242 patients had patent contralateral carotid (group II). All patients were operated under general
anaesthesia, and selective shunting was based on somatosensory evoked potentials (SEPs). Ultrasonographic follow-up was
performed at 1, 6 and 12 months and then once a year. Early results and follow-up data were analysed retrospectively.
Results: in group I there was a significantly higher incidence of SEPs reduction and shunt insertion; however, there were
no differences in terms of perioperative complications. The cumulative stroke and death rate at 30 days in group 1 and group
2 were 2.4% vs 1.4% (p n.s.), respectively. At a mean follow-up of 15 months there were no differences between the two
groups in terms of cumulative symptom-free survival.
Conclusions: the presence of contralateral carotid occlusion caused an increased use of shunt, but not in early complica-
tions rates.
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Carotid endarterectomy (CEA) was demonstrated to
be effective in stroke prevention both in moderate and
severe symptomatic carotid artery stenoses and in
severe asymptomatic ones.
The level of benefit of CEA in stroke prevention is
inversely related to perioperative mortality/neuro-
logical morbidity rates: to achieve potential benefits
over medical therapy, surgical risks of surgery must
be maintained under 5% in symptomatic patients and
3% in asymptomatic ones.1,2
Some international randomised trials have stated
that the presence of contralateral carotid occlusion
carries a higher perioperative risk both in sympto-
matic and in asymptomatic patients.3,4
As a consequence of these results, patients with
contralateral carotid artery occlusion have been con-
sidered by some authors as ideal candidate to endo-
vascular treatment.5 However, most of the published
series do not agree with these conclusions, reportingPlease address all correspondence to: R. Pulli, UniveritaÁ degli
Studi di Firenze, Azienda Ospedaliera Careggi Cattedra di Chirur-
gia Vascolare, Viale Morgagni 85, 50134 Firenze, Italy.
1078±5884/02/010063  06 $35.00/0 # 2002 Elsevier Science Ltd. Alno early and long-term significative differences in
patients with or without contralateral carotid occlusion.
The aim of this paper is to evaluate early and mid-
term results of CEA in patients with contralateral
carotid occlusion, compared with results in patients
without it in a single centre series.
Materials and Methods
A retrospective analysis of a prospectively compiled
database concerning all CEAs carried out at our
Institution between 1996 and 1999 was performed.
Eighty-two CEAs in patients with contralateral
carotid artery occlusion (group 1) were compared
with those performed in 1242 patients without con-
tralateral occlusion (group 2).
All the patients underwent preoperative duplex-
scanning, computed tomography scan of cerebral
parenchyma and digital subtraction angiography in
double projection. Degree of stenosis was determined
by mean of the NASCET method.3 The status of verte-
bral arteries and of intracranial vessels was also exam-
ined during angiography.l rights reserved.
Table 2. Univariate analysis for shunt insertion rates.
Group 1 Group 2
Chi-square p Chi-square p
Ispilateral vertebral
Disease
1.1 0.2 1.5 0.2
Contralateral vertebral
disease
0.04 1 0.5 0.4
Ipsilateral intracranial
stenosis
± ± 0.2 1
Contralateral intracranial
stenosis
1.0 0.3 7.5 0.1
Table 1. Demographic data and risk factors.
Group 1
(82 pts)
Group 2
(1242 pts)
p
Male 64 (78%) 858 (69%) n.s.
Female 18 (22%) 384 (31%) n.s.
Mean age (range) 69 (47±85) 70 (44±89) n.s.
Smoke 70 (85%) 867 (70%) n.s.
Hypertension 43 (53%) 710 (57%) n.s.
Hypercholesterolemia 31 (38%) 468 (38%) n.s.
Diabetes 11 (13%) 236 (19%) n.s.
Cardiac disease 17 (20%) 237 (19%) n.s.
History of AMI 9 (11%) 176 (14%) n.s.
History of PAOD 35 (43%) 466 (37%) n.s.
Pts.patients; AMI acute myocardial infarction; PAOD
peripheral arterial obstructive disease.
64 R. Pulli et al.All the interventions were performed under general
anaesthesia: somatosensory evoked potentials (SEPs)
were used to monitor cerebral status during surgical
intervention and to indicate when the use of shunt
was necessary. Criterion for shunt insertion was
defined as a reduction of N20/P25 waves higher
than 75% of baseline values.6 At the end of inter-
vention completion study with angiography was
routinely performed. Perioperative mortality and
neurological morbidity in the two groups rates were
analysed and compared by mean of chi-square test or
Fisher test when necessary.7 Univariate and multivari-
ate analysis (stepwise logistic regression analysis) of
general characteristics, vascular risk factors and
intraoperative variables for 30-days perioperative
risk of stroke and death were performed.
Clinical and ultrasonographic follow-up was per-
formed at 1, 6, 12 months and then once a year. All
studies were performed using the Acuson Sequoia 512
Ultrasound System (Acuson Corporation, Mountain
View, Ca.). A 8L5 linear array probe with an operating
frequency of 8.0±5.0 MHz was used in all the cases.
Follow-up data were analysed by life-table analysis
(Kaplan±Meier test) and results in subgroups were
compared by means of log rank test.
Statistical analysis was done by means of SPSS 10.0
program for Windows (SPSS Inc., Chicago, U.S.A.).
Results
The two groups were homogeneous with respect
to sex and age. No differences were found between
the two groups considering common risk factors for
atherosclerosis and cardiovascular comorbidities
(Table 1).
No significative differences were found concerning
preoperative neurological status dependent on
operated carotid (64.2% of asymptomatic patients in
group 1 and 59.7% in group 2, respectively). Consider-
ing contralateral symptoms, patients in group 1 had a
significative higher incidence of preoperative TIA,
minor stroke and major stroke than those in group 2
(p5 0.001).
When considering ipsilateral cerebral parenchyma
status, no significative differences were found
between the two groups. Patients with contralateral
carotid occlusion had a higher incidence of contralat-
eral cerebral lesions detected on computed tomog-
raphy scan or magnetic resonance imaging
(p5 0.001).
There were no differences between the two groups
regarding angiographic degree of stenosis on the
operated side.Eur J Vasc Endovasc Surg Vol 24, July 2002In group 1 intraoperative monitoring showed a stat-
istically significative higher incidence of SEPs reduc-
tion than in group 2 (20.7% vs 5.5%; p 0.004); the
cumulative rate of shunt insertion was 25.6% in
group 1 and 6.9% in group 2 (p 0.001). The status
of vertebral arteries and intracranial vessels did not
influence shunt insertion rate (Table 2).
There were no differences between the two groups
in terms of perioperative complications. Considering
the presence of neurological deficits at awake, no dif-
ferences were found between the two groups: in
group 1 there were no neurological deficits at awake,
as in group 2 this rate was 1.7% (pn.s.). In group 1,
two neurological events happened in postoperative
period, at 4 h and 1 h from awake, respectively.
Mortality and neurological morbidity at 30 days
were also similar in the two groups: stroke rate was
2.4% (one disabling and one non disabling stroke)
in group 1 and 1.1% in group 2 (pn.s.); no deaths
were found in group 1, as in group 2 mortality was
0.3% (pn.s.). The cumulative stroke and death rate
was 2.4% in group 1 and 1.4% in group 2 (pn.s.)
Multiple regression analysis did not demonstrate
contralateral carotid occlusion to be an indipendent
predictor of operative stroke or death. In this analysis
hypertension and shunt insertion were found
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(Table 3).
Follow-up was performed in 1227 patients (96.7%),
with a mean duration of 15 months (range 1±57).
During follow-up there were thirty-nine deaths, one
in group 1, due to contralateral major stroke, and the
remaining in group 2: causes were in 4 patients neu-
rologic events, in 5 malignancies, in 17 coronary dis-
eases, in 2 ruptured abdominal aortic aneurysms, in 1
repiratory distress. In 9 cases the cause of death was
unknown. There were nine neurologic events ipsilat-
eral to operated carotid artery, one in group 1, due to
transient ischemic attack (TIA), and eight in group 2
(4 TIAs, 2 minor strokes and 2 major strokes).
Estimated cumulative 24 months-survival was
96.5% in group 1 and 94% in group 2 (pn.s.)Table 3. Multiple regression analysis of operative risk for stroke
and death.
Risk factor Odds ratio (95% CI) p
Hypertension 3.79 1.06±13.50 0.04
Female gender 0.28 0.06±1.27 0.1
Vertebral disease 7.35 0.84±64 0.07
Patch closure 0.39 0.14±1.13 0.08
Use of shunt 11.81 3.99±34.93 50.0001
Variables not included in model: smoking (p 0.83); diabetes
mellitus (p 0.3); hyperlipidemia (p 0.5); history family (p 0.69);
peripheral vascular disease (p 0.77); cardiac disease (p 0.61);
previous TIA or stroke (p 0.51); ipsilateral CT or MR lesions
(p 0.51); contralateral CT or MR lesions (p 0.62); stenosis of
intracranial carotid artery (p 0.87); occlusion of contralateral
carotid artery (p 0.99).
Fig. 1. Kaplan±Meier curve: survival for group 1 vs group 2 with
number of patients at risk.(Fig. 1); estimated symptoms-free survival at 24
months was 96.8% in group 1 and 98.8% in group 2
(pn.s.) (Fig. 2).
Discussion
Untreated patients with severe carotid stenosis and
contralateral carotid artery occlusion are supposed to
have a higher risk of stroke attributable to their sten-
otic lesion than patients with a patent contralateral
artery.3 Starting from these data, the benefit of CEA
in patients with contralateral carotid artery occlusion
was recently and largely debated. Results in the 1415
patients of surgical arm of NASCET8 showed that the
presence of carotid artery occlusion contralateral to
symptomatic carotid stenosis is associated with a 2.2
folds increase of perioperative risk of stroke and
death. However, the number of patients with contral-
ateral carotid occlusion was relatively small, and data
derived from a post-hoc analysis, which had not the
same relevance of an appositely designed trial. In ACE
trial4 contralateral carotid occlusion was identified as
a factor that 2.3 folds increased perioperative risk of
stroke and death. However, ACE trial was a `` medical''
trial, not designed to exclusively study this subgroup
of patients, and nearly half of the interventions were
not performed by vascular surgeons.
These data are rather different from those in ECST
trial,9 where contralateral carotid occlusion is not
individuated in a multiple regression analysis as a
statistically significant risk factor.Fig. 2. Kaplan±Meier curve: symptoms-free for group 1 vs group 2
with number of patients at risk.
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66 R. Pulli et al.Considering patients with severe asymptomatic
stenosis and contralateral occlusion, a review of data
from ACAS10 recently showed no significative differ-
ences in early results in both group; however, in
patients with contralateral occlusion, surgery was
associated with an unacceptable 2% increase in
5-year stroke risk with respect to best medical treat-
ment. Surprisingly, the authors conclude that this dif-
ference is primarily attributable to low long-term risk
for medically managed patients with contralateral
occlusion, which is a finding in contrast with estab-
lished Literature. In fact, patients with carotid stenosis
and contralateral carotid occlusion are supposed to
be at significant risk for disease progression.11
Mukherjee et al.12 suggested that these findings are
the result of an overestimation of carotid stenosis by
duplex scanning, used as the sole diagnostic assess-
ment in most part of patients, in the presence of con-
tralateral occlusion, and concluded that ACAS patients
had substantially 560% carotid stenosis in the treated
artery, which is a demonstrated degree of stenosis
unlikely to be associated with any benefit with surgery.
Analysis of international randomised trials substan-
tially differ from results of large community observa-
tional studies: in fact, the review of available
published series from Medline research from 1990Table 4. Main published series in literature from 1990.
Authors (year) n pat Contralater
occlusion (n
W. C. Mackey et al. (1990)25 670 63
M. A. Mattos et al. (1992)26 544 66
B. A. Perler et al. (1992)27 205 36
C. Jansen et al. (1993)28 130 25
L. B. Goldstein et al. (1993)29 697 48
M. D'Addato et al. (1993)30 167 167
F. B. Meyer et al. (1993)31 357 357
W. J. McCarthy et al. (1993)32 526 81
T. S. Riles et al. (1994)33 2336 346
G. P. Deriu et al. (1994)34 439 61
A. P. Gasecki et al. (1995) (NASCET trial)3 659 43
M. A. Adelman et al. (1995)35 180 180
P. Cao et al. (1995)36 367 55
K. A. Coyle et al. (1996)19 116 116
A. F. da Silva et al. (1996)13 700 108
P. M. Rothwell et al. (1997) (ECST trial)9 1509 48
E. Ballotta et al. (1998)37 388 57
M. Aungst et al. (1998)38 37 37
R. K. Samson et al. (1998)16 654 67
D. W. Taylor et al. (1999) (ACE trial)4 2804 236
P. B. Dimakakos et al. (1999)18 235 40
W. H. Baker et al. (2000) (ACAS trial)10 737 86
A. F. AbuRahma et al. (2000)39 399 49
R. Karmeli et al. (2001)15 144 50
Present series 1324 82
r.r. relative risk; n.s.not significative; sig. significative (value not
Eur J Vasc Endovasc Surg Vol 24, July 2002demonstrate a trend towards a higher complication
rate in patients with contralateral occlusion, but
these differences never reach statistical significance
(Table 4). Also in our series there were no early and
long-term differences between the two groups and
early and late results were similar. Perioperative com-
plication rate was always mantained under 3%, which
represents the recommended standard from inter-
national randomised trials and guidelines.2
In our series we had an higher incidence of shunt
insertion in the presence of contralateral occlusion
rather than in the presence of patent contralateral
artery in our series: this result is similar to other pub-
lished series.13±15 However, both in all these reports
and in our study, in spite of higher incidence of
shunt insertion in patients with contralateral occlu-
sion, there were no differences in term of periopera-
tive complications.
In our series the use of a selective criterion for shunt
insertion permitted to reduce its use under 30% of the
cases in patients with contralateral occlusion, which
represents the lowest value in all the published series.
In our experience shunt insertion rate was not influ-
enced neither by ipsi- or contralateral vertebral
disease nor by ipsi- or contralateral intracranial
carotid stenosis.al
pat)
Perioperative
Maior Neurologic
events (%)
Perioperative Maior
Neurologic events (%)
without contralateral
occlusion
p
4.8 2.6 n.s.
3.0 2.9 n.s.
2.8 4.7 n.s.
4.0 5.7 n.s.
10.4 8.3 n.s.
4.8 ± ±
0.6 ± ±
4.9 2.5 n.s.
3.7 2.7 n.s.
1.7 0.3 n.s.
14.3 4 (contralateral stenosis)
5 (contralateral patency)
sig.
0.7 ± ±
0 2.7 n.s.
4.3 ± n.s.
5.6 2.4 n.s.
12.5 7.3 n.s.
3.5 1.0 n.s.
5.0 ± n.s.
3.0 3.3 n.s.
r.r. 2.3 ± sig.
2.5 2.5 n.s.
2.3 2.2 n.s.
2.0 2.9 n.s.
2.1 2.1 n.s.
2.4 1.1 n.s.
reported).
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basis of a safe, validated and affidable cerebral mon-
itoring method may represent an acceptable strategy
to reduce perioperative risk even in patients with
contralateral carotid occlusion.16±19
An interesting finding in our series is that post-
operative neurological events in group 1 occurred in
a delayed fashion on the day of surgery, while no
deficits were detected at awake. Similar findings
were reported in NASCET trial,5 where three post-
operative strokes in patients with contralateral occlu-
sion developed 1, 1 and 3 h after waking respectively.
Interpretation of these data is not easy: it is possible
that thromboembolic events are more frequent in this
patients, who could particularly suffer from hemody-
namic modifications which are frequent in immediate
perioperative period. Ipsilateral neurological symp-
toms during follow-up were rare in both groups, and
the commonest cause of death was coronary artery
disease.20
In the last years the endovascular approach has
been proposed in management of extracranial carotid
artery disease. Indications and results of endovascular
therapy being still uncertain,21 it has been proposed
that its use must be reserved to high-risk patients
(unstable angina, previous ipsilateral CEA, severe
comorbid illnesses, contralateral carotid occlusion).22
Results in the published series do not differ from those
obtained with surgical treatment.5,23,24
In other words, the assumption that contralateral
carotid artery occlusion represents an adjunctive sur-
gical risk factor for perioperative and long term mor-
tality/neurological morbidity is unacceptable. From
our series and from most published data, this assump-
tion appears at least debatable, and, in our opinion,
contralateral carotid artery occlusion does not repre-
sent an indication to CAS.
References
1 Biller J, Feinberg WM, Castaldo JE et al. Guidelines for caro-
tid endarterectomy: a statement for healthcare professionals
from a special writing group of the stroke council, American
Heart Association. Stroke 1998; 29: 554±562.
2 Goldstein LB, Adams R, Becker K et al. Primary prevention of
ischemic stroke: a statement for healthcare professionals from
the stroke council of the American Heart Association. Stroke
2000; 32: 280±299.
3 Gasecki AP, Eliasziw M, Ferguson GG, Hachinski V,
Barnett HJM. Long-term prognosis and effect of endarterect-
omy in patients with symptomatic severe carotid stenosis and
contralateral carotid stenosis or occlusions: results from NAS-
CET. J Neurosurg 1995; 83: 778±782.
4 Taylor DW, Barnett HJM, Haynes RB et al. Low-dose and
high-dose acetylsalicilic acid for patients undergoing carotid
endarterectomy: a randomised controlled trial. Lancet 1999; 353:
2179±2184.5 Mericle RA, Kim SH, Lanzino G et al. Carotid artery angio-
plasty and use of stents in high-risk patient with contralateral
occlusions. J Neurosurg 1999; 90: 1031±1036.
6 Amantini A, Bartelli M, De Scisciolo G et al. Monitoring of
somatosensory evoked potentials durino carotid endarterect-
omy. J Neurol 1992; 239: 241±247.
7 Subcommittee on Reporting Standards for Cerebrovascular
Disease. Suggested standards for reports dealing with cerebro-
vascular disease. J Vasc Surg 1988; 8: 721±729.
8 Ferguson GG, Eliasziw M, Barr HWK et al. The North
American Symptomatic Carotid Endarterectomy Trial. Surgical
results in 1415 patients. Stroke 1999; 30: 1751±1758.
9 Rothwell PM, Slattery J, Warlow CP. Clinical and angio-
graphic predictors of stroke and death from carotid endarterect-
omy: sistematic review. BMJ 1997; 315: 1571±1577.
10 Baker WH, Howard VJ, Howard G, Toole JF. Effect of contra-
lateral occlusion on long-term efficacy of endarterectomy in the
Asymptomatic Carotid Atherosclerosis Study (ACAS). Stroke
2000; 31: 2330±2334.
11 Brengman ML, O'Donnell SD, Mullenix P, Goff JM,
Gillespie DL, Rich NM. The fate of a patent carotid artery
contralateral to an occlusion. Ann Vasc Surg 2000; 14: 77±81.
12 Mukherjee D, Yadav JS, Howard VJ, Howard G, Baker WH.
Effect of contralateral occlusion on long-term efficacy of endar-
terectomy in the Asymptomatic Carotid Atherosclerosis Study
(ACAS). Response. Stroke 2001; 32: 1443±1448.
13 Da Silva AF, McCollum P, Szymanska T, De Cossart L.
Prospective study of carotid endarterectomy and contralateral
carotid occlusion. Br J Surg 1996; 83: 1370±1372.
14 Julia P, Chemla E, Mercier F, Renaudin JM, Fabiani JN.
Influence of the status of the contralateral carotid artery on the
outcome of carotid surgery. Ann Vasc Surg 1998; 12: 566±571.
15 Karmely R, Lubezky H, Alak M, Loberman Z, Weller B,
Fajer S. Carotid endarterectomy in awake patients with contral-
ateral carotid artery occlusion. Cardiovasc Surg 2001; 9: 334±338.
16 Samson RH, Showalter DP, Yunis JP. Routine carotid endarter-
ectomy without a shunt, even in the presence of a contralateral
occlusion. Cardiovasc Surg 1998; 6: 475±484.
17 Frawley JE, Hicks RG, Gray LJ, Niesche JW. Carotid endar-
terectomy without a shunt for symptomatic lesions associated
with contralateral severe stenosis or occlusion. J Vasc Surg 1996;
23: 421±427.
18 Dimakakos PB, Antoniou A, Papasava M, Mourikis D,
Rizos D. Carotid endarterectomy without protective measures
in patients with occluded and non occluded contralateral carotid
artery. J Cardiovasc Surg 1999; 40: 849±855.
19 Coyle KA, Smith RB, Salam AA, Dodson TF, Chaikof IL,
Lumsden AB. Carotid endarterectomy in patients with contra-
lateral carotid occlusion: review of a 10-year experience. Cardio-
vasc Surg 1996; 4: 71±75.
20 Chemla E, Julia P, Chatellier G et al. Influence of coronary
artery and contralateral carotid artery status on long-term results
of carotid artery surgery. Ann Vasc Surg 2000; 14: 334±339.
21 Crawley F, Brown MM. Percutaneous transluminal angioplasty
and stenting for carotid artery stenosis. Cochrane Database Syst
Rev 2001; CD 000515.
22 Shawl F, Kadro W, Domanski MJ et al. Safety and efficacy of
elective carotid artery stenting in high risk patients. J Am Coll
Cardiol 2000; 35: 1721±1728.
23 Mathur A, Roubin GS, Gomez CR, Iyer SS, Wong PM,
Piamsomboon C, Yadav SS, Dean LS, Vitek JJ. Elective carotid
artery stenting in the presence of contralateral occlusion. Am J
Cardiol 1998; 81: 1315±1317.
24 Roubin GS, New G, Iyer SS et al. Immediate and late clinical
outcome of carotid artery stenting in patients with symptomatic
and asymptomatic carotid artery stenosis. A 5-year prospective
analysis. Circulation 2001; 103: 532±537.
25 Mackey WC, O'Donnell TF, Callow AD. Carotid endarte-
rectomy contralateral to an occluded carotid artery: perioperative
risk and late reuslts. J Vasc Surg 1990; 11: 778±783.
26 Mattos MA, Barkmeier LD, Hodgson KJ, Ramsey DE,
Sumner DS. Internal carotid artery occlusion: operative risksEur J Vasc Endovasc Surg Vol 24, July 2002
68 R. Pulli et al.and long-term stroke rates after contralateral carotid endarte-
rectomy. Surgery 1992; 11: 670±679.
27 Perler BA, Burdick JF, Williams JM. Does contralateral inter-
nal carotid artery occlusion increase the risk of carotid endarte-
rectomy? J Vasc Surg 1992; 16: 347±353.
28 Jansen C, Vriens EM, Eickleboom BC, Vermeulen FEE,
van Gijn J, Ackerstaff RGA. Carotid endarterectomy with
transcranial doppler and electroencephalographic monitoring: a
prospective study in 130 operations. Stroke 1993; 24: 665±669.
29 Goldstein LB, McCrory C, Landsmann PB, Samsa JP,
Ancukiewicz M, Oddone EZ. Multicenter review of preopera-
tive risk factors for carotid endarterectomy in patients with
ipsilateral symptoms. Stroke 1994; 25: 1116±1121.
30 D'Addato M, Pedrini L. Carotid stenosis associated with con-
tralateral carotid occlusion. J Mal Vasc 1993; 18: 229±232.
31 Meyer FB, Fode NC, Marsh WR, Piepgras DG. Carotid endar-
terectomy in patients with contralateral carotid occlusion. Mayo
Clin Proc 1993; 68: 337±342.
32 McCarthy WJ, Wang R, Pearce WH, Flinn WR, Yao JS.
Carotid endarterectomy with an occluded contralateral carotid
artery. Am J Surg 1993; 166: 168±171.
33 Riles TS, Imparato AM, Iacobwitz CR, Lamparello PJ,
Giangola J, Adelman MA. The cause of perioperative stroke
after carotid endarterectomy. J Vasc Surg 1994; 19: 206±216.
34 Deriu GP, Franceschi L, Milite D et al. Carotid artery
endarterectomy in patients with contralateral carotid arteryEur J Vasc Endovasc Surg Vol 24, July 2002occlusion: perioperative hazards and later results. Ann Vasc
Surg 1994; 8: 337±342.
35 Adelman MA, Iacobowitz CR, Riles TS et al. Carotid endarte-
rectomy in the presence of contralateral occlusion: a review of
315 cases over a 27-year experience. Cardiovasc Surg 1995; 3: 307±
312.
36 Cao PG, Giordano G, De Rango P, Ricci S, Zannetti S,
Moggi L. Carotid endarterectomy contralateral to an occluded
carotid artery: a retrospective case-control study. Eur J Vasc
Endovasc Surg 1995; 10: 16±22.
37 Ballotta E, Da Giau G, Guerra M. Carotid endarterectomy
and contralateral internal carotid artery occlusion: perioperative
risks and long-term stroke and survival rates. Surgery 1998; 123:
234±240.
38 Aungst M, Gahtan V, Berkowitz H, Roberts AB,
Kerstein MD. Carotid endarterectomy outcome is not affected
in patients with a contralateral carotid artery occlusion. Am J
Surg 1998; 176: 30±33.
39 AbuRahma AF, Robinson P, Holt SM, Herzog TA, Mowery NT.
Perioperative and late stroke rates of carotid endarterectomy
contralateral to carotid artery occlusion. Results from a rando-
mized trial. Stroke 2000; 31: 1566±1571.
Accepted 31 January 2002
